About Kay Wagoner
Form D filings for Med Aditus Pharmaceuticals in 2024 list Kay Wagoner as director.
Kay Wagoner first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Kay Wagoner in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kay Wagoner works with at each company, as listed on that company's latest Form D.
Med Aditus Pharmaceuticals, Inc. · Form D, Nov 6, 2024
DS
David Stefanich
Director
KR
Khama Rogo
Director
MG
Mary Gunn
Director
DT
Dhiren Thakker
President and CEO, director